September 2015 | OncologyLive

Olaparib Studies Put Focus on BRCA-Positive Breast Cancers

January 30, 2016

The identification of the BRCA1 and BRCA2 tumor suppressor genes and the recognition that inherited loss of function (deleterious) mutations in one of these important genes places women at high risk for the development of breast, ovarian, and other cancers are major advances in women’s health research.

A Leader's Legacy: Transforming the American Cancer Society

September 15, 2015

John R. Seffrin, PhD, who was honored with a 2014 Giants of Cancer Care® award, has spent his career helping to advance cancer prevention through education and public policy initiatives as a volunteer and as a longtime leader at the American Cancer Society.

Value-Based Care: Why Include Factors Beyond Oncologists' Control?

September 14, 2015

How can any analysis of the quality of cancer care being delivered by providers that focuses on a survival outcome as the ultimate measure of that quality-rather than on an evaluation of the optimization of the care process-be considered objectively valid and clinically meaningful?